Food Supplement CONDITION LET’S C FAMILY

1. Product Information
Product Name: Food Supplement CONDITION LET’S C FAMILY
Ingredients: In 1 powder sachet contains: Vitamin C (L-Ascorbic acid) 500 mg, Zinc (Zinc oxide) 1.275 mg, Vitamin B2 (Riboflavin) 0.7 mg.
Other ingredients: Natural sweeteners (Xylitol, Enzyme-modified Stevia); synthetic sweeteners (Dextrose Anhydrous, Sucralose); Natural flavoring (Lemon flavor powder); Lemon juice powder; Stabilizer (Cyclodextrin syrup powder); Filler (Hydroxypropyl methylcellulose (HPMC)); Anti-caking agent (Silicon dioxide).
Uses: Supplements Vitamin C, Zinc, and Vitamin B2 to help strengthen the body’s resistance, support antioxidant capacity, and enhance iron absorption.
Target users: Children and adults in need of Vitamin C supplementation. People with weak resistance.
2. Cautions and Usage Instructions
Directions for use: Consume directly or mix with cool water.
Storage: Store at room temperature, avoid humidity and direct sunlight. Keep out of reach of children.
Shelf life: 36 months from the date of manufacture. See “MFD” and “EXP” on the product packaging for manufacturing and expiry dates.
Net weight: 60g/Box (2g/sachet x 30 sachets).
Note: This product is not a medicine and is not intended to replace medical treatment. Do not use for people who are hypersensitive or allergic to any ingredients of the product. Adolescent females or those with prolonged menstruation, pregnant women, and breastfeeding women need Vitamin C supplementation to increase iron absorption. Consult a professional before use if using with other iron-containing products or taking medication.
3. Origin
Origin: South Korea.
Manufacturer: NOVAREX Co., Ltd. Address: 80, Osongsaengmyeong 14-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, South Korea.
Imported, distributed and quality responsibility by: HANKOL HEALTHCARE VINA CO., LTD. Address: 7th Floor, CJ Building, 2Bis-4-6 Le Thanh Ton, Saigon Ward, Ho Chi Minh City, Vietnam.
Product License No.: 2424/2022/ĐKSP
Advertisement License No.: 1170/2022/XNQC-ATTP